Figure 4
Figure 4. B abortus–treated mice have shortened RBC lifespan and evidence of hemolysis. (A) The RBC biotinylation assay indicates a 2.7-fold increase in RBC destruction in B abortus–treated mice (−4%/day vs −1.7%/day). Means ± SD. *P < .05 and **P < .001 by Student t test or Mann-Whitney U test. Overall difference between the 2 sets of measurements is significant at P < .001 by 2-way analysis of variance (Holm-Sidak method). (B) Peripheral blood smears of B abortus–injected mice 2 weeks after showing schistocytes and erythrocyte membrane irregularities, consistent with mild microangiopathic hemolysis. Arrows point to damaged erythrocytes, shown magnified in the right margin.

B abortustreated mice have shortened RBC lifespan and evidence of hemolysis. (A) The RBC biotinylation assay indicates a 2.7-fold increase in RBC destruction in B abortustreated mice (−4%/day vs −1.7%/day). Means ± SD. *P < .05 and **P < .001 by Student t test or Mann-Whitney U test. Overall difference between the 2 sets of measurements is significant at P < .001 by 2-way analysis of variance (Holm-Sidak method). (B) Peripheral blood smears of B abortusinjected mice 2 weeks after showing schistocytes and erythrocyte membrane irregularities, consistent with mild microangiopathic hemolysis. Arrows point to damaged erythrocytes, shown magnified in the right margin.

Close Modal

or Create an Account

Close Modal
Close Modal